ஹூ தடுப்பூசி கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SII to seek WHO s approval for supplying 200 million doses of Covid vaccines to GAVI-COVAX alliance
SII to seek WHO s approval for supplying 200 million doses of Covid vaccines to GAVI-COVAX alliance
The Serum Institute of India (SII) has also announced that it will sell doses of its Covid-19 vaccine Covishield to the Centre at Rs 200 per dose while the same will be sold at Rs 1,000 per dose in the private market.
advertisement
UPDATED: January 12, 2021 19:27 IST
Trucks being used to transport Covishield from SII s facility in Pune s Pimpri Chinchwad (Photo Credits: PTI)
One of the world s largest vaccine makers, Pune-based Serum Institute of India (SII) will supply 200 million doses of its Covid-19 vaccine to the WHO s GAVI-COVAX alliance in the next few weeks, sources told India Today. ....

Oxford Astrazeneca Covishield , Tedros Ghebreyesus , Adar Poonawalla , Adar Poonawala , Serum Institute , While The Serum Institute , Melinda Gates Foundation , Serum Institute Of India , World Health Organisation , Pune Based Serum Institute , World Health , India Today , Melinda Gates , Business Today , Who 039s Gavi Covax Alliance , Sii Who Vaccine , Sii Covishield Vaccine , Sii Covid Vaccine , Who Vaccine Alliance , அடார் பூனாவல்ல , அடார் பூனாவள , சீரம் நிறுவனம் , போது தி சீரம் நிறுவனம் , மெலிண்டா வாயில்கள் அடித்தளம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,